← Leaderboards
Sara Hagg
Karolinska Institute
$2,535,580
Attributed
$2,535,580
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,535,580 · 2
By mechanism
RF1$1,562,430 · 1
R01$973,150 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCellsAnti AgingBiological AgingCaenorhabditis ElegansAgingAge EffectAstrocytosisAge RelatedAmyloid Beta-42Abeta AccumulationAmyloid Beta-Protein PrecursorAnimal ModelAnimalsAdoptionAging BrainCell ModelAutophagocytosisBaltimoreAlzheimer Disease PreventionBasic ScienceBeta Amyloid PathologyAmyloid Beta-ProteinCost Effective
Grant awards (3)
Repurposing drugs for Alzheimer´s disease using a reverse translational approach$484,519
R01 · FY2025 · AG · contact PI
Repurposing drugs for Alzheimer´s disease using a reverse translational approach$488,631
R01 · FY2024 · AG · contact PI
Repurposing drugs for Alzheimer´s disease using a reverse translational approach$1,562,430
RF1 · FY2021 · AG · contact PI